|
1981
|
|
|
Solute carrier organic anion transporter family member 6A1 |
CT48, GST, OATP-I, OATP6A1, OATPY |
|
|
1982
|
|
|
PPARG coactivator 1 beta |
ERRL1, PERC, PGC-1(beta), PGC1B |
Basal cell neoplasm, Breast cancer, Mammary neoplasms, Breast carcinoma, Carcinoma, Hyperlipidemia, Malignant melanoma of skin, Marfan syndrome, Melanoma, Melanosis, Obesity, Vitiligo |
|
1983
|
|
|
EGF like, fibronectin type III and laminin G domains |
AGRINL, AGRNL, PIKA |
|
|
1984
|
|
|
NAD kinase 2, mitochondrial |
C5orf33, DECRD, MNADK, NADKD1 |
2,4-dienoyl-coa reductase deficiency, Central visual impairment, Cerebellar atrophy, Cerebral atrophy, Choreoathetosis, Developmental delay, Epileptic encephalopathy, Hyperlysinemia, Hypoplasia of corpus callosum, Leukodystrophy, Microcephaly, Hypotonia, Nystagmus, Pancreatitis, Progressive encephalopathy with leukodystrophy, Quadriplegia, Sleep apneaView all (2 more) |
|
1985
|
|
|
Cytochrome c oxidase subunit 6A1 |
CMTRID, COX6A, COX6AL |
|
|
1986
|
|
|
Cytochrome c oxidase subunit 6A2 |
COX6AH, COXVIAH, COXVIa-M, MC4DN18 |
|
|
1987
|
|
|
Adenosine A1 receptor |
RDC7 |
Asthma, Cerebral infraction, Catalepsy, Cerebral ischemia, Cerebral thrombosis, Colorectal cancer, Myocardial infarction, Respiratory tract diseases, Schizophrenia, Subarachnoid hemorrhage, Transient ischemic attack |
|
1988
|
|
|
Cytochrome c oxidase subunit 6B1 |
COX6B, COXG, COXVIb1, MC4DN7 |
Anemia, Cytochrome-c oxidase deficiency, Developmental delay, Fanconi syndrome, Hearing loss, High palate, Hypertrophic cardiomyopathy, Isolated cytochrome c oxidase deficiency, Leukoencephalopathy, Mental retardation, Mitochondrial diseases, Motor delay, Optic atrophy, Phosphate diabetes, Ptosis, Renal tubular disorder, Retinitis pigmentosaView all (2 more) |
|
1989
|
|
|
Ubiquitin conjugating enzyme E2 QL1 |
- |
|
|
1990
|
|
|
POU domain class 5, transcription factor 2 |
SPRM-1 |
|
